Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hueber

Showing results (521-530 of 570) with videos related to

Pageof 57
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritisMariola Kurowska-Stolarska, Stefano Alivernini, Lucy E Ballantine, et al.
Nephron. Physiology|April 25, 2009
OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variabilityAntony E Shrimpton, Richard R Hoopes, Stephen J Knohl, et al.
Redox Biology|July 21, 2023
Corrigendum to "Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer" [Redox Biol. 34 (2020) 101528]R González, M A Rodríguez-Hernández, M Negrete, et al.
Redox Biology|May 11, 2020
Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancerRaúl González, María A Rodríguez-Hernández, María Negrete, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 7, 2019
Anterograde ejaculation preservation after endoscopic treatments in patients with bladder outlet obstruction: systematic review and pooled-analysis of randomized clinical trialsGiovanni E Cacciamani, Frederico Cuhna, Alessandro Tafuri, et al.
Frontiers in Pharmacology|October 18, 2019
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the USChiara Whichello, Eline van Overbeeke, Rosanne Janssens, et al.
Frontiers in Public Health|March 11, 2022
Patient's Perception of Digital Symptom Assessment Technologies in Rheumatology: Results From a Multicentre StudyJohannes Knitza, Felix Muehlensiepen, Yuriy Ignatyev, et al.
Annals of the Rheumatic Diseases|May 7, 2021
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseasesDavid Simon, Koray Tascilar, Filippo Fagni, et al.
Lancet (London, England)|August 3, 2024
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging studyBenjamin A Fisher, Xavier Mariette, Athena Papas, et al.
The Patient|June 22, 2019
Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USARosanne Janssens, Selena Russo, Eline van Overbeeke, et al.
Pageof 57

Showing results (521-530 of 570) with videos related to

Sort By:
Pageof 57
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritisMariola Kurowska-Stolarska, Stefano Alivernini, Lucy E Ballantine, et al.
Nephron. Physiology|April 25, 2009
OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variabilityAntony E Shrimpton, Richard R Hoopes, Stephen J Knohl, et al.
Redox Biology|July 21, 2023
Corrigendum to "Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer" [Redox Biol. 34 (2020) 101528]R González, M A Rodríguez-Hernández, M Negrete, et al.
Redox Biology|May 11, 2020
Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancerRaúl González, María A Rodríguez-Hernández, María Negrete, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 7, 2019
Anterograde ejaculation preservation after endoscopic treatments in patients with bladder outlet obstruction: systematic review and pooled-analysis of randomized clinical trialsGiovanni E Cacciamani, Frederico Cuhna, Alessandro Tafuri, et al.
Frontiers in Pharmacology|October 18, 2019
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the USChiara Whichello, Eline van Overbeeke, Rosanne Janssens, et al.
Frontiers in Public Health|March 11, 2022
Patient's Perception of Digital Symptom Assessment Technologies in Rheumatology: Results From a Multicentre StudyJohannes Knitza, Felix Muehlensiepen, Yuriy Ignatyev, et al.
Annals of the Rheumatic Diseases|May 7, 2021
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseasesDavid Simon, Koray Tascilar, Filippo Fagni, et al.
Lancet (London, England)|August 3, 2024
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging studyBenjamin A Fisher, Xavier Mariette, Athena Papas, et al.
The Patient|June 22, 2019
Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USARosanne Janssens, Selena Russo, Eline van Overbeeke, et al.
Pageof 57